Compare CINT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CINT | BVS |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 566.6M | 482.9M |
| IPO Year | 2021 | 2016 |
| Metric | CINT | BVS |
|---|---|---|
| Price | $5.00 | $8.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $6.80 | ★ $13.33 |
| AVG Volume (30 Days) | 155.5K | ★ 241.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.12 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $573,280,000.00 |
| Revenue This Year | $13.00 | N/A |
| Revenue Next Year | $12.62 | $6.78 |
| P/E Ratio | ★ $17.94 | $74.21 |
| Revenue Growth | N/A | ★ 11.89 |
| 52 Week Low | $3.98 | $5.81 |
| 52 Week High | $7.28 | $11.25 |
| Indicator | CINT | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 69.18 |
| Support Level | $4.93 | $6.27 |
| Resistance Level | $5.24 | $9.03 |
| Average True Range (ATR) | 0.19 | 0.36 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 72.41 | 85.60 |
CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.